FDA Inspection 1328790 — Aizant Drug Research Solutions Private Ltd.
The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on Jul 31, 2026 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 31, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 1219 | 21 CFR 211.67(b)(2) | Cleaning SOPs/schedules |
| 1833 | 21 CFR 211.84(d)(1) | Identity Testing of Each Component |
| 3565 | 21 CFR 211.58 | Buildings not maintained in good state of repair |